Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:54:58.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces an NIH transition notice about using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:37:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T19:32:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:24:47.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the former content with an error page. This change blocks access to the study details, contacts, locations, and related documents that users expect to see on the page.
    Difference
    19%
    Check dated 2026-09-19T22:03:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing the prior Revision: v3.6.5. This reflects a minor update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-29T18:54:06.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.